Cas9 Stable Cell Line - KYSE-150

The KYSE-150 cell line, derived from human esophageal squamous cell carcinoma, is an important model for studying esophageal cancer biology. The Cas9 Stable Cell Line - KYSE-150 is a genetically engineered variant in which the Cas9 endonuclease is stably integrated into the KYSE-150 genome. This modification ensures stable, long-term expression of the Cas9 protein without the need for repeated transfection. Its key characteristics include robust Cas9 activity, compatibility with standard cell culture protocols, and preservation of parental cell line characteristics relevant to cancer research. This engineered cell line eliminates the variability introduced by transient transfection methods, providing researchers with a reliable platform for precise gene manipulation.

The Cas9 Stable Cell Line - KYSE-150 can be applied in oncology and functional genomics. This cell line is primarily used for efficient gene knockout studies to explore tumor suppressor genes, oncogenes, and signaling pathways involved in esophageal cancer development. Researchers use this cell line for genome-wide CRISPR screening to identify novel therapeutic targets or resistance mechanisms in the context of chemotherapy and radiotherapy. Furthermore, this cell line supports precise gene knock-in experiments to introduce point mutations, tag or reporter gene constructs to mimic cancer-related gene alterations. This cell line is of immeasurable value for in vitro and in vivo studies exploring tumor progression, metastasis, and drug sensitivity.